20 completed, 4 withdrawn, 1 active not recruiting, 1 not yet recruiting. 27 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 27 | Completed 20, Withdrawn 4, Active not recruiting 1, Not yet recruiting 1, Suspended 1 |
Follow Eye Infections, Bacterial: new trials by email Literature Review of Eye Infections, Bacterial trials Research Report on Eye Infections, Bacterial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma Ivermectin - Survival of Flies Developing in Faecal Samples | Phase 4 | Not yet recruiting | London School of Hygiene and Tropical Medicine | 12 | 2026-10-05 | 2026-10-30 |
| Trachoma Elimination Study by Focused Antibiotic (TESFA) Azithromycin mass treatment, Azithromycin targeted treatment - Trachoma | Phase 4 | Withdrawn | Emory University | 2025-06-01 | 2025-07-16 | |
| Azithromycin Reduction to Reach Elimination of Trachoma B Azithromycin - Trachoma | Phase 4 | Withdrawn | University of California, San Francisco | 2024-10-01 | 2026-03-13 | |
| Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures 0.9% Bacteriostatic Local Anesthetic Injection, 1% Lidocaine with 1:100,000 epinephrine Local Anesthetic Injection, Eyelid Lesion Removal - Eyelid Tumor, Eyelid Bump | Phase 4 | Completed | University of California, San Francisco | 95 | 2022-05-17 | 2025-07-08 |
| Enhancing the A in SAFE for Trachoma Azithromycin for Routine Community-wide MDA, Two Additional Rounds of Azithromycin for Children, Azithromycin for Second Community-wide MDA - Trachoma | Phase 4 | Completed | Emory University | 34630 | 2022-05-04 | 2024-02-29 |
| Kebele Elimination of Trachoma for Ocular Health Azithromycin - Trachoma | Phase 4 | Active not recruiting | University of California, San Francisco | 320000 | 2022-02-07 | 2025-10-23 |
| Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin Administration of Albendazole on Day 1, Administration of Ivermectin on Day 1, Administration of Azithromycin on Day 1 - Trachoma, Lymphatic Filariases | Phase 4 | Completed | London School of Hygiene and Tropical Medicine | 13511 | 2021-12-01 | 2022-08-19 |
| Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine Betadine, Avenova - Eye Infections, Bacterial | Phase 4 | Suspended | University of Miami | 230 | 2021-08-06 | 2025-07-10 |
| Azithromycin Reduction to Reach Elimination of Trachoma Azithromycin - Trachoma | Phase 4 | Completed | University of California, San Francisco | 3931 | 2021-05-29 | 2026-03-25 |
| Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso Azithromycin, Amoxicillin, Cotrimoxazole - Child Development | Phase 4 | Completed | University of California, San Francisco | 252 | 2017-07-04 | 2023-03-02 |
| Mortality Reduction After Oral Azithromycin: Morbidity Study Azithromycin, Placebo - Childhood Mortality | Phase 4 | Completed | University of California, San Francisco | 72000 | 2014-11-01 | 2021-03-17 |
| Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis azithromycin, ivermectin, albendazole - Trachoma, Lymphatic Filariasis | Phase 4 | Withdrawn | Emory University | 2014-02-01 | 2014-05-22 | |
| Tripartite International Research for the Elimination of Trachoma mass treatment with oral azithromycin - Trachoma, Chlamydia | Phase 4 | Completed | University of California, San Francisco | 29000 | 2010-11-01 | 2017-10-11 |
| Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment Vigamox Ophthalmic Solution, BSS placebo - Bacterial Conjunctivitis | Phase 4 | Completed | Alcon Research | 24 | 2008-10-01 | 2010-03-31 |
| Partnership for Rapid Elimination of Trachoma Azithromycin - Trachoma | Phase 4 | Completed | Johns Hopkins University | 128 | 2008-05-01 | 2017-07-18 |
| A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery Trichiasis surgery with absorbable sutures, Trichiasis surgery with non-absorbable sutures - Trachomatous Trichiasis, Trachoma | Phase 4 | Completed | London School of Hygiene and Tropical Medicine | 1300 | 2008-03-01 | 2012-01-12 |
| Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger Azithromcyin, Azithromycin - Trachoma, Chlamydia Trachomatis | Phase 4 | Completed | University of California, San Francisco | 1139 | 2008-01-01 | 2012-05-08 |
| A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis gatifloxacin, moxifloxacin 0.5% eye drops - Bacterial Conjunctivitis | Phase 4 | Completed | Allergan | 171 | 2007-06-01 | 2011-09-21 |
| Pediatric Zylet Safety and Efficacy Study loteprednol etabonate/tobramycin opthalmic suspension, vehicle - Chalazion, Hordeolum | Phase 4 | Completed | Bausch & Lomb Incorporated | 108 | 2006-11-01 | 2011-10-07 |
| Steroids for Corneal Ulcers Trial Antibiotics, Topical corticosteroid, Placebo - Corneal Ulcer, Eye Infections, Bacterial | Phase 4 | Completed | Thomas M. Lietman | 500 | 2006-09-01 | 2018-08-01 |
Showing 20 of 27. Sign in to see all of them.
Trachoma (20) · Chlamydia Infections (5) · Bacterial Infections (4) · Conjunctivitis, Bacterial (3) · Eye Diseases (3) · Elephantiasis, Filarial (2) · Hordeolum (2) · Infections (2) · Chalazion (1) · Communicable Diseases (1) · Corneal Ulcer (1) · Diarrhea (1) · Eyelid Neoplasms (1) · Health Education (1)
Bacterial Infections and Mycoses (27) · Eye Infections (27) · Infections (25) · Eye Diseases (24) · Bacterial Infections (23) · Conjunctival Diseases (23) · Conjunctivitis (23) · Corneal Diseases (21) · Chlamydiaceae Infections (20) · Conjunctivitis, Bacterial (20) · Gram-Negative Bacterial Infections (20) · Chlamydia Infections (15) · Communicable Diseases (5) · Genital Diseases (5)
Azithromycin (12) · Moxifloxacin (3) · Ivermectin (2) · Adrenal Cortex Hormones (1) · Albendazole (1) · Amoxicillin (1) · Anti-Bacterial Agents (1) · Gatifloxacin (1) · Hypochlorous Acid (1) · Lidocaine (1) · Loteprednol Etabonate (1) · Ophthalmic Solutions (1) · Permethrin (1) · Povidone-Iodine (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
University of California, San Francisco (11) · Johns Hopkins University (4) · Emory University (3) · London School of Hygiene and Tropical Medicine (3) · Alcon Research (2) · Allergan (1) · Bausch & Lomb Incorporated (1) · Thomas M. Lietman (1) · University of Miami (1)
United States (16) · Ethiopia (6) · Niger (3) · United Kingdom (3) · Tanzania (2) · Burkina Faso (1) · Canada (1) · Democratic Republic of the Congo (1) · India (1) · Malawi (1) · Mozambique (1) · South Sudan (1)
Tom Lietman, MD (3) · Catherine Oldenburg, ScD, MPH (2) · Elodie Lebas, RN (2) · Julius Schachter, PhD (2) · Kieran S O'Brien, MPH (2) · Paul Emerson, PhD (2) · Sheila K West (2) · Thomas M Lietman, MD (2) · Tom M Lietman, MD (2) · Abdou Amza, MD (1) · Catherine E Oldenburg, ScD (1) · Chandler R Dawson, MD (1) · Elodie J Lebas, RN (1) · Hadley Burroughs, MSPH (1) · Huub C Gelderblom, MD, PhD, MPH (1)
PMID 16905024, PMID 18829631, PMID 19329003, PMID 21072224, PMID 21685340, PMID 21987582, PMID 22095569, PMID 22159005, PMID 22180732, PMID 22192488, PMID 22395880, PMID 22447793, PMID 22545165, PMID 22736616, PMID 22953007, PMID 22959881, PMID 23307105, PMID 23326612, PMID 23385795, PMID 23392481, PMID 23785525, PMID 24315294, PMID 24433194, PMID 24612976, PMID 24618327, PMID 24621121, PMID 25002297, PMID 25407464, PMID 25858004, PMID 26302380, PMID 26489933, PMID 27631025, PMID 27956455, PMID 28351345, PMID 28402408, PMID 28893761, PMID 29088030, PMID 29260659, PMID 29561511, PMID 29897440, PMID 30014828, PMID 30106956, PMID 30151409, PMID 30419040, PMID 30515431, PMID 30689671, PMID 30895203, PMID 30950493, PMID 31166952, PMID 31237871
5UG1EY030833 (2), R01AI048789 (2), 1UG1EY028088 (1), U10EY015114 (1)